✦ LIBER ✦

Intelligence and cognitive function in children and adolescents with spinal muscular atrophy

✍ Scribed by A. von Gontard; K. Zerres; M. Backes; C. Laufersweiler-Plass; C. Wendland; P. Melchers; G. Lehmkuhl; S. Rudnik-Schöneborn

Book ID: 117669484
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 80 KB
Volume: 12
Category: Article
ISSN: 0960-8966
DOI: 10.1016/s0960-8966(01)00274-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cognitive function in children with spin

Cognitive function in children with spinal muscular atrophy

✍ Jechil S Sieratzki; Bencie Woll 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Muscle strength and motor function in ch

Muscle strength and motor function in children and adolescents with spinal muscular atrophy II and III

✍ ANNA-KARIN KROKSMARK; EVA BECKUNG; MáR TULINIUS 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Behavioural problems in children and ado

Behavioural problems in children and adolescents with spinal muscular atrophy and their siblings

✍ C Laufersweiler-Plass; S Rudnik-Schöneborn; K Zerres; M Backes; G Lehmkuhl; A vo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Cognitive functions in duchenne muscular

Cognitive functions in duchenne muscular dystrophy: A reappraisal and comparison with spinal muscular atrophy

✍ Billard, C.; Gillet, P.; Signoret, J.L.; Uicaut, E.; Bertrand, P.; Fardeau, M.; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 729 KB

Response to comments by J.S. Sieratzki a

Response to comments by J.S. Sieratzki and B. Woll: Cognitive function in children with spinal muscular atrophy

✍ A von Gontard; S Rudnik-Schoeneborn; K Zerres 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 30 KB

Compound muscle action potential and mot

Compound muscle action potential and motor function in children with spinal muscular atrophy

✍ Aga Lewelt; Kristin J. Krosschell; Charles Scott; Ai Sakonju; John T. Kissel; Th 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

## Abstract Reliable outcome measures that reflect the underlying disease process and correlate with motor function in children with SMA are needed for clinical trials. Maximum ulnar compound muscle action potential (CMAP) data were collected at two visits over a 4–6‐week period in children with SM